Table 2.
Clinical characteristics
| Overall | Treatment non-adherence based on Morisky-Green baseline score | ||||
|---|---|---|---|---|---|
| High-Risk | Low-Risk | p-value | |||
| N = 114 | 27 (23.7) | 87 (76.3) | |||
| Time of evolution of COPD (years) | |||||
| Mean (S.D.) | 8.8 (6.8) | 7.7 (6.2) | 9.2 (7.0) | 0.314U | |
| Missing | 1 | 0 | 1 | ||
| Number of moderate exacerbations in the last 12 months | |||||
| Mean (S.D.) | 1.6 (1.1) | 1.5 (0.8) | 1.6 (1.2) | 0.967U | |
| Missing | 0 | 0 | 0 | ||
| Number of severe exacerbations in the last 12 months | |||||
| Mean (S.D.) | 1.2 (1.6) | 0.7 (1.0) | 1.4 (1.8) | 0.049U | |
| Missing | 0 | 0 | 0 | ||
| Total number of exacerbations in the last 12 months | |||||
| Mean (S.D.) | 2.8 (1.4) | 2.2 (0.5) | 3.0 (1.5) | 0.003U | |
| 2–3 exacerbations | n(%) | 97 (85.1) | 26 (96.3) | 71 (81.6) | 0.069F |
| 4 or more exacerbations | n(%) | 17 (14.9) | 1 (3.7) | 16 (18.4) | |
| Missing | 0 | 0 | 0 | ||
| Comorbidities | |||||
| Cardiac comorbidities | n(%) | 41 (36.0) | 8 (29.6) | 33 (37.9) | 0.432C |
| Coronary heart disease (CHD) | n(%) | 22 (19.3) | 4 (14.8) | 18 (20.7) | 0.499C |
| Peripheral vascular disease | n(%) | 13 (11.4) | 2 (7.4) | 11 (12.6) | 0.730F |
| Missing | n | 0 | 0 | 0 | |
COPD chronic obstructive pulmonary disease, S.D standard deviation
CChi-square test; FFisher’s exact test; UMann-Whitney U test